David J. Kopecky

2.4k citations

12 papers · 1.2k indexed · 1 hit paper · h-index 11

Co-authors: Scott D. Rychnovsky Hou Chen Bryant H. Yang Andrew G. Myers James L. Gleason Lydia McKinstry Frank Kayser Nigel P.C. Walker
Topics: Asymmetric Synthesis and Catalysis (3 papers)Chemical Synthesis and Analysis (2 papers)Drug Transport and Resistance Mechanisms (2 papers)
Cited by: Organic Chemistry Biotechnology Inorganic Chemistry
Journals: Journal of the American Chemical Society PLoS ONE Journal of Medicinal Chemistry
Partner nations: United States

In The Last Decade

David J. Kopecky

12 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pseudoephedrine as a Practical Chiral Auxiliary for the Synthesis of Highly Enantiomerically Enriched Carboxylic Acids, Alcohols, Aldehydes, and Ketones

1997 489 citations Andrew G. Myers, Bryant H. Yang et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by David J. Kopecky

Since Specialization

Citations

This map shows the geographic impact of David J. Kopecky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Kopecky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Kopecky more than expected).

Fields of papers citing papers by David J. Kopecky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Kopecky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Kopecky. The network helps show where David J. Kopecky may publish in the future.

Co-authorship network of co-authors of David J. Kopecky

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Kopecky. A scholar is included among the top collaborators of David J. Kopecky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Kopecky. David J. Kopecky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Systematic Study of the Glutathione Reactivity of N -Phenylacrylamides: 2. Effects of Acrylamide Substitution 2020 ·Journal of Medicinal Chemistry ·(unknown),David J. Kopecky,Laurie P. Volak,Michael D. Bartberger,Yuping Chen,Christopher M. Tegley,Tara Arvedson,John D. McCarter,Christopher Fotsch,Victor J. Cee	44
2	Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate 2016 ·PLoS ONE ·Ingrid C. Rulifson,Ping Cao,(unknown),David J. Kopecky,Linda Huang,Ryan D. White,(unknown),Jonitha Gardner,Xiaosu Wu,Kui Chen,Trace S. Tsuruda,Oliver Homann,Hélène Baribault,Harvey Yamane,(unknown),J.J.W. Wiltzius,Yang Li	25
3	Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Xian‐Yun Jiao,David J. Kopecky,Jinsong Liu,Jinqian Liu,Juan C. Jaén,Mario Cardozo,Rajiv Sharma,Nigel P.C. Walker,Holger Wesche,Shyun Li,Ellyn Farrelly,Shou-Hua Xiao,Zhulun Wang,Frank Kayser	58
4	Discovery and optimization of a series of liver X receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Xian‐Yun Jiao,David J. Kopecky,(unknown),Derek E. Piper,Marc Labelle,(unknown),Martin Harrison,Stuart A. Jones,Juan C. Jaén,Andrew K. Shiau,(unknown),Jean Danao,(unknown),Peter Coward,Frank Kayser	16
5	Discovery of a new binding mode for a series of liver X receptor agonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·David J. Kopecky,(unknown),(unknown),(unknown),Marc Labelle,Derek E. Piper,Peter Coward,Andrew K. Shiau,(unknown),Jean Danao,(unknown),Juan C. Jaén,Frank Kayser	10
6	Structure-Guided Design, Synthesis, and Evaluation of Guanine-Derived Inhibitors of the eIF4E mRNA–Cap Interaction 2012 ·Journal of Medicinal Chemistry ·Xiaoqi Chen,David J. Kopecky,Jeff Mihalic,Shawn Jeffries,Xiaoshan Min,Julie A. Heath,(unknown),Sujen Lai,Zice Fu,Cristiano R. W. Guimarães,(unknown),Shyun Li,Sheree Johnstone,(unknown),Haoda Xu,Mario Cardozo,Shen Wang,Nigel P.C. Walker,Frank Kayser,Zhulun Wang	190
7	Thermodynamic Analysis of mRNA Cap Binding by the Human Initiation Factor eIF4E via Free Energy Perturbations 2009 ·Journal of the American Chemical Society ·Cristiano R. W. Guimarães,David J. Kopecky,Jeff Mihalic,(unknown),Shawn Jeffries,Stephen T. Thibault,Xiaoqi Chen,Nigel P.C. Walker,Mario Cardozo	13
8	Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·David J. Kopecky,Xiaolin Hao,Yi Chen,Jiasheng Fu,Xian‐Yun Jiao,Juan C. Jaén,Mario Cardozo,Jinsong Liu,Zhulun Wang,Nigel P.C. Walker,Holger Wesche,Shyun Li,Ellyn Farrelly,Shou-Hua Xiao,Frank Kayser	31
9	Mukaiyama Aldol−Prins Cyclization Cascade Reaction: A Formal Total Synthesis of Leucascandrolide A 2001 ·Journal of the American Chemical Society ·David J. Kopecky,Scott D. Rychnovsky	152
10	Improved Procedure for the Reductive Acetylation of Acyclic Esters and a New Synthesis of Ethers 1999 ·The Journal of Organic Chemistry ·David J. Kopecky,Scott D. Rychnovsky	140
11	Asymmetric Synthesis of 1,3-Dialkyl-Substituted Carbon Chains of any Stereochemical Configuration by an Iterable Process 1997 ·Synlett ·Andrew G. Myers,Bryant H. Yang,Hou Chen,David J. Kopecky	54
12	Pseudoephedrine as a Practical Chiral Auxiliary for the Synthesis of Highly Enantiomerically Enriched Carboxylic Acids, Alcohols, Aldehydes, and Ketonesbreakdown → 1997 ·Journal of the American Chemical Society ·Andrew G. Myers,Bryant H. Yang,Hou Chen,Lydia McKinstry,David J. Kopecky,James L. Gleason	489

About David J. Kopecky

David J. Kopecky is a scholar working on Organic Chemistry, Biochemistry and Oncology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (3 papers), Chemical Synthesis and Analysis (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Organic Chemistry (986 citations), Biotechnology (168 citations) and Inorganic Chemistry (145 citations). David J. Kopecky has collaborated with scholars based in United States. Frequent co-authors include Scott D. Rychnovsky, Hou Chen, Bryant H. Yang, Andrew G. Myers, James L. Gleason, Lydia McKinstry, Frank Kayser, Nigel P.C. Walker, Mario Cardozo and Shyun Li. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact